The Readout Loud
Episode 193: Jared Holz on Biotech's red tape, plus the latest billionaire science project
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
With biotech in the dumps, we talk to Oppenheimer analyst Jared Holz about why the world has soured on the sector and what it means for the future of medicine. Then, STAT’s Matthew Herper joins us to explain the latest big idea from biotech's big thinkers: a company called Altos Labs, which has raised $3 billion to do something or other. We also discuss the latest news in the life sciences, with a cameo from Shkreli and an update on Omicron.